Mayne Pharma Group Ltd (MYX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2010 | 06-2009 | 06-2008 | 06-2007 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 19,791 | 15,096 | 22,806 | 15,354 |
| Receivables | 4,221 | 78 | 94 | 160 |
| Inventories | 12,999 | N/A | N/A | N/A |
| Other current assets | 321 | 37 | 70 | 70 |
| TOTAL | $37,654 | $15,249 | $23,041 | $15,654 |
| Non-Current Assets | ||||
| PPE Net | 32,710 | -31 | 18 | 52 |
| Intangibles | 14,617 | N/A | N/A | N/A |
| Other Non-Current Assets | 3,347 | 0 | 0 | 0 |
| TOTAL | $50,674 | $-31 | $18 | $52 |
| Total Assets | $88,328 | $15,218 | $23,059 | $15,706 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 15,175 | N/A | 3 | 3 |
| Accounts payable and accrued liabilities | 3,927 | 233 | 229 | 986 |
| Other current liabilities | 6,549 | 2 | N/A | N/A |
| TOTAL | $34,972 | $517 | $371 | $1,815 |
| Non-Current Liabilities | ||||
| Long Term Debt | 2,194 | N/A | 2 | 6 |
| Other Non-Current Liabilities | 17,320 | 27 | 0 | 0 |
| TOTAL | $25,064 | $27 | $4 | $11 |
| Total Liabilities | $60,036 | $544 | $375 | $1,826 |
| Shareholders' Equity | ||||
| Common Shares | 29,649 | 15,869 | 15,869 | 15,908 |
| Retained earnings | -5,814 | -9,067 | -5,306 | -1,833 |
| Other shareholders' equity | 3,428 | 1,805 | 875 | 439 |
| TOTAL | $27,264 | $8,607 | $11,438 | $14,514 |
| Total Liabilities And Equity | $87,300 | $9,151 | $11,813 | $16,340 |